Poxel S.A. is a biopharmaceutical company based in Lyon, France, focused on developing innovative treatments for metabolic diseases, primarily type 2 diabetes and non-alcoholic steatohepatitis (NASH). Founded in 2009 as a spin-off from Merck Serono, Poxel is advancing its lead product, Imeglimin, through Phase III clinical trials; this oral anti-diabetic candidate targets organ functions affected by diabetes, such as the pancreas, liver, and muscles. The company is also developing PXL770, currently in Phase IIa trials, which activates the adenosine monophosphate-activated protein kinase (AMPK) to manage energy metabolism, and PXL065, a mitochondrial pyruvate carrier inhibitor in Phase I trials for NASH. Additionally, Poxel has a licensing agreement with Enyo Pharma for the development of PXL007, an FXR agonist in Phase I studies for hepatitis B and NASH. The company’s pipeline reflects its commitment to addressing critical targets in cellular energy regulation, which are vital for treating metabolic disorders.
Faron is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline focusing on acute organ traumas, vascular damage and cancer immunotherapy.
Caresyntax Inc. develops a technology platform specializing in surgical analytics to enhance safety and efficiency in hospitals and ambulatory surgical centers. The company offers solutions designed to identify and manage risks, automate workflows, and reduce variability in surgical procedures. Its flagship products include qvident, a performance management software that enables surgical teams to create and share surgical content, and PRIME365, an integration platform that consolidates key surgical data from various sources such as video, audio, patient vitals, and procedural timestamps. Caresyntax's offerings support a range of surgical procedures, from minimally invasive to robotic surgeries, and can be deployed as HIPAA-compliant software through on-premise, cloud-based, or hybrid installations. Established in 1991, Caresyntax is headquartered in Boston, Massachusetts.
Caresyntax Inc. develops a technology platform specializing in surgical analytics to enhance safety and efficiency in hospitals and ambulatory surgical centers. The company offers solutions designed to identify and manage risks, automate workflows, and reduce variability in surgical procedures. Its flagship products include qvident, a performance management software that enables surgical teams to create and share surgical content, and PRIME365, an integration platform that consolidates key surgical data from various sources such as video, audio, patient vitals, and procedural timestamps. Caresyntax's offerings support a range of surgical procedures, from minimally invasive to robotic surgeries, and can be deployed as HIPAA-compliant software through on-premise, cloud-based, or hybrid installations. Established in 1991, Caresyntax is headquartered in Boston, Massachusetts.
Lumeon Ltd. is a digital health company specializing in care pathway management solutions for the healthcare sector. Founded in 2005 and headquartered in London, the company offers a cloud-based platform known as the Care Pathway Manager, which provides a comprehensive, real-time view of the patient journey from referral to outcome. Lumeon's services encompass business analysis, project management, data migration, training, and ongoing support. By focusing on the entire care pathway, Lumeon aids healthcare providers in optimizing clinical and administrative workflows, automating tasks, and achieving measurable healthcare outcomes. The company serves a diverse range of clients, including some of Europe's leading healthcare organizations. Lumeon was previously known as Qinec Ltd. before rebranding in July 2016.
Caresyntax Inc. develops a technology platform specializing in surgical analytics to enhance safety and efficiency in hospitals and ambulatory surgical centers. The company offers solutions designed to identify and manage risks, automate workflows, and reduce variability in surgical procedures. Its flagship products include qvident, a performance management software that enables surgical teams to create and share surgical content, and PRIME365, an integration platform that consolidates key surgical data from various sources such as video, audio, patient vitals, and procedural timestamps. Caresyntax's offerings support a range of surgical procedures, from minimally invasive to robotic surgeries, and can be deployed as HIPAA-compliant software through on-premise, cloud-based, or hybrid installations. Established in 1991, Caresyntax is headquartered in Boston, Massachusetts.
Lumeon Ltd. is a digital health company specializing in care pathway management solutions for the healthcare sector. Founded in 2005 and headquartered in London, the company offers a cloud-based platform known as the Care Pathway Manager, which provides a comprehensive, real-time view of the patient journey from referral to outcome. Lumeon's services encompass business analysis, project management, data migration, training, and ongoing support. By focusing on the entire care pathway, Lumeon aids healthcare providers in optimizing clinical and administrative workflows, automating tasks, and achieving measurable healthcare outcomes. The company serves a diverse range of clients, including some of Europe's leading healthcare organizations. Lumeon was previously known as Qinec Ltd. before rebranding in July 2016.
SpineGuard SA specializes in the design, development, and marketing of medical devices for spinal surgery, with a focus on enhancing the safety and precision of pedicle screw placement. The company's flagship product line, PediGuard, includes various probes such as the PediGuard Straight, Curved, and Cannulated, designed to facilitate screw placement while minimizing radiation exposure during procedures. Additionally, SpineGuard offers the DSG Connect app for signal collection during drilling and the DSG smart screw for efficient screw placement. Founded in 2009 and headquartered in Vincennes, France, SpineGuard aims to establish PediGuard as the standard of care in spinal surgery, benefiting patients, surgeons, and healthcare providers. The company continues to explore further applications of its technology to align with its mission of improving surgical outcomes.
Genesis Automation USA, Inc. specializes in supplies management, analytics, and traceability solutions tailored for the healthcare sector. The company focuses on enhancing clinical and patient outcome data management, facilitating patient-level cost tracking, conducting product safety reviews, and performing comparative value analysis. Its automated solutions enable clinicians to efficiently track patient interactions with caregivers and biomedical technologies. Additionally, Genesis offers an automated supply management system that allows healthcare professionals to monitor supplies and devices throughout the internal distribution process. The company has established strategic partnerships with organizations such as HFMA and the Healthcare Costing for Value Institute. Founded in 2016, Genesis Automation USA, Inc. is headquartered in Hermosa Beach, California, with an additional office in St. Petersburg, Florida, and operates as a subsidiary of Genesis Automation UK Ltd.
Genesis Automation is a single source, full-service automated system solutions provider. It designs and builds high-precision assembly, test, and special process equipment for a wide range of industries. Genesis Automation was founded in 1999 and is based in Cork, Ireland.
Lumeon Ltd. is a digital health company specializing in care pathway management solutions for the healthcare sector. Founded in 2005 and headquartered in London, the company offers a cloud-based platform known as the Care Pathway Manager, which provides a comprehensive, real-time view of the patient journey from referral to outcome. Lumeon's services encompass business analysis, project management, data migration, training, and ongoing support. By focusing on the entire care pathway, Lumeon aids healthcare providers in optimizing clinical and administrative workflows, automating tasks, and achieving measurable healthcare outcomes. The company serves a diverse range of clients, including some of Europe's leading healthcare organizations. Lumeon was previously known as Qinec Ltd. before rebranding in July 2016.
Mauna Kea Technologies SA is a medical device company headquartered in Paris, France, specializing in the development and marketing of imaging technologies for the diagnosis and treatment of cancer and other diseases. Its primary product, Cellvizio, is a confocal laser endomicroscopy platform that allows real-time, in vivo microscopic visualization of tissues at the cellular level. This technology aids physicians in accurately detecting early-stage pathologies and making informed therapeutic decisions. The company operates globally, with a significant presence in Europe, the United States, and various countries in Asia and Latin America. Mauna Kea Technologies generates revenue primarily from the sales of Cellvizio products and related accessories used in medical diagnostics and research.
Impeto Medical SAS is a privately owned medical device company based in Paris, France, founded in 2005. The company specializes in the manufacture and marketing of non-invasive diagnostic devices that assess eccrine sweat gland activity. Its key products include SUDOSCAN+, which detects and monitors peripheral autonomic neuropathy; EZSCAN, designed for screening and preventing diabetes and metabolic risks; and SUDOSCAN, which evaluates galvanic skin response to analyze sympathetic nervous system behavior in various conditions, such as diabetes and Parkinson's disease. Impeto Medical utilizes patented technology to assess sudomotor function, enabling healthcare providers to screen large patient populations and identify diseases at an early stage. The company distributes its products through a network of distributors and operates subsidiary locations in China and San Diego, California.
Neuravi Limited is a medical device company based in Galway, Ireland, focused on developing clot retrieval devices to restore blood flow in patients who have experienced ischemic strokes caused by arterial blockages in the brain. The company offers the EmboTrap revascularization devices, which are designed for the treatment of acute ischemic strokes and are available in several European countries, including Belgium, Denmark, France, Germany, and Spain. Founded in 2009, Neuravi operates in the emerging neurointerventional device market and collaborates with researchers and clinicians to advance treatment solutions for this serious condition. As of April 2017, Neuravi is a subsidiary of DePuy Ireland Unlimited Company.
i-Optics is a medical device company based in The Hague, Netherlands, specializing in advanced corneal diagnostic solutions. Founded in 2006, it focuses on empowering cataract surgeons by providing a comprehensive suite of examinations necessary for toric, multifocal, and extended depth of focus intraocular lens implantation. Its technology includes corneal topography, posterior corneal analysis, mesopic and photopic pupillometry, and full-color photography, all designed to enhance the understanding of corneal properties. By employing innovative techniques such as ray tracing and a unique LED positioning system, i-Optics aims to improve surgical outcomes and increase the volume of premium patient care.
Genesis Automation USA, Inc. specializes in supplies management, analytics, and traceability solutions tailored for the healthcare sector. The company focuses on enhancing clinical and patient outcome data management, facilitating patient-level cost tracking, conducting product safety reviews, and performing comparative value analysis. Its automated solutions enable clinicians to efficiently track patient interactions with caregivers and biomedical technologies. Additionally, Genesis offers an automated supply management system that allows healthcare professionals to monitor supplies and devices throughout the internal distribution process. The company has established strategic partnerships with organizations such as HFMA and the Healthcare Costing for Value Institute. Founded in 2016, Genesis Automation USA, Inc. is headquartered in Hermosa Beach, California, with an additional office in St. Petersburg, Florida, and operates as a subsidiary of Genesis Automation UK Ltd.
SpineGuard SA specializes in the design, development, and marketing of medical devices for spinal surgery, with a focus on enhancing the safety and precision of pedicle screw placement. The company's flagship product line, PediGuard, includes various probes such as the PediGuard Straight, Curved, and Cannulated, designed to facilitate screw placement while minimizing radiation exposure during procedures. Additionally, SpineGuard offers the DSG Connect app for signal collection during drilling and the DSG smart screw for efficient screw placement. Founded in 2009 and headquartered in Vincennes, France, SpineGuard aims to establish PediGuard as the standard of care in spinal surgery, benefiting patients, surgeons, and healthcare providers. The company continues to explore further applications of its technology to align with its mission of improving surgical outcomes.
Mainstay Medical Holdings plc is a medical device company based in Dublin, Ireland, with operations in the United States and Australia. Founded in 2008, the company specializes in developing and commercializing ReActiv8, an implantable neurostimulation system aimed at treating chronic low back pain. This innovative therapy is designed to restore control to the muscles that stabilize the lumbar spine, addressing a significant unmet need in the healthcare market. By collaborating with scientists and clinical experts, Mainstay Medical focuses on delivering effective solutions for patients suffering from debilitating pain, ultimately enhancing their quality of life.
i-Optics is a medical device company based in The Hague, Netherlands, specializing in advanced corneal diagnostic solutions. Founded in 2006, it focuses on empowering cataract surgeons by providing a comprehensive suite of examinations necessary for toric, multifocal, and extended depth of focus intraocular lens implantation. Its technology includes corneal topography, posterior corneal analysis, mesopic and photopic pupillometry, and full-color photography, all designed to enhance the understanding of corneal properties. By employing innovative techniques such as ray tracing and a unique LED positioning system, i-Optics aims to improve surgical outcomes and increase the volume of premium patient care.
EOS Imaging is a medical technology company that specializes in developing and marketing advanced imaging solutions for osteoarticular conditions, particularly in orthopedics. The company offers an innovative imaging system, EOS, which captures low-dose, full-body, and stereo-radiographic images of patients in functional positions. It also provides the EOSedge system for high-quality imaging, the sterEOS workstation for 3D modeling from simultaneous frontal and lateral EOS images, and EOSapps for online surgical planning based on unbiased, weight-bearing images. Additionally, EOS Imaging develops software for knee and hip surgery planning and manufactures patient-specific cutting guides for orthopedic procedures. With a strong international presence, the company markets its products in Europe, the Middle East, Africa, North America, the Asia-Pacific, and Latin America. Founded in 1989 and headquartered in Paris, France, EOS Imaging has established itself as a leader in personalized imaging solutions for orthopedic care.
Mendor is a Finnish company focused on designing, developing, and marketing innovative diabetes management products. It has introduced a portable, all-in-one blood glucose meter alongside a web-based software application aimed at facilitating daily diabetes management. Mendor's products are developed in collaboration with users and diabetes experts to meet the specific needs of individuals who require regular blood glucose monitoring. Additionally, the company offers patented software systems that provide real-time data on diabetic care, which enhances the efficacy and efficiency of diabetes treatment for both patients and caregivers.
BONESUPPORT is a medical technology company dedicated to the development of injectable osteoconductive biomaterials for the treatment of fragility fractures caused by osteoporosis, and bone voids or gaps caused by trauma, disease or related to surgical procedures. The company's mission is to restore health to enhance the quality of life for patients with bone disorders.
BONESUPPORT was founded on 2000 and is headquartered in Lund, Sweden.